Cigna price target lowered to $339 from $420 at Barclays

Barclays analyst Andrew Mok lowered the firm’s price target on Cigna (CI) to $339 from $420 and keeps an Overweight rating on the shares post the Q4 report. While Cigna’s stop loss issue appears to be contained to its individual stop loss book, the magnitude of the issue sews doubt into broader commercial trends and is worth monitoring closely, the analyst tells investors in a research note.